Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD LSEG Data AD CME Group Education AD Bank of England Statistics AD Investing.com Markets
Venues & MTFs

Novacyt H1 Loss Narrows As Revenue Rises 18%

By Nasdaq Market Structure

Novacyt H1 Loss Narrows As Revenue Rises 18%

(RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services, reported higher revenue and a narrower loss for the six months ended June 30, 2026.

Read at source

Read also
  1. Lilly's EloraTZP Delivers Weight Loss Results In Phase 2b Trial
  2. Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It's Not Too Late to Buy the Stock.
  3. Vanguard vs. Fidelity High-Dividend ETFs: Which Fits Your Income Strategy?
  4. Wheat Falls Lower on Wednesday, Fading a Tighter Stocks Number
  5. Stocks Climb on Signs of Lower Inflation and Stronger US Growth

Source: Nasdaq Market Structure